Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 4 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 5INDUSTRY 4OTHER_GOV 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Lymphoid 4Gastrointestinal 4Other hematologic neoplasm 2Tumor-Agnostic 1Thoracic 1Other solid neoplasm 1Dermatologic 1

Conditions

Stomach Neoplasms 2Colorectal Neoplasms 1Cholangiocarcinoma 1

Interventions

Gemcitabine 302Fluorouracil 296Oxaliplatin 269Bevacizumab 267Capecitabine 233Leucovorin 229pembrolizumab 215Irinotecan 185Cisplatin 142Cetuximab 142Nivolumab 131Paclitaxel 117130-nm albumin-bound paclitaxel 117Sorafenib 86Albumin-Bound Paclitaxel 75Docetaxel 65regorafenib 64atezolizumab 64IFL protocol 61Folfox protocol 61Trastuzumab 55Panitumumab 47durvalumab 46Ramucirumab 43Injections 43Sunitinib 41Drug Therapy 41Carboplatin 40trifluridine tipiracil drug combination 38lenvatinib 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Rabeprazole × Gastrointestinal × Clear all
NCT05930119 2023-09-06

HMPL-453 Food Effect and PPI Study in Healthy Volunteer Study

Hutchmed

Phase 1 Completed
24 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT02638584 2020-07-31

Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.

Il-Yang Pharm. Co., Ltd.

Phase 4 Completed
176 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03260179 2017-08-24

Study to Evaluate the Safety, Preliminary Efficacy and Pharmacokinetics of 3810

Haihe Biopharma Co., Ltd.

Phase 1 Unknown
60 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01264822 2017-02-27

Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori

Eisai Inc.

Completed
108 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡